BMC Cancer · 2006 · 92 citations · 26 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMedical OncologyCombination ChemotherapyHepatocellular CarcinomaHepatocellular Carcinoma PharmacotherapyLiver CancerLiver MetastasisMetastatic Disease TreatmentCapecitabine-based TherapyCombination Drug TherapyDrug Combination TherapyHepatobiliary Cancer Systemic TherapyHepatocellular Carcinoma MetastasisHepatocellular Carcinoma TreatmentLiver Metastases TreatmentMetastatic Liver Disease Treatment
BACKGROUND: Although numerous chemotherapeutic agents have been tested, the role of systemic chemotherapy for hepatocellular carcinoma (HCC) has not been clarified. New therapeutic strategies are thus needed to improve outcomes, and we designed this study with new effective drug combination. METHODS: Twenty-nine patients with histologically-confirmed, metastatic HCC received a combination chemotherapy with doxorubicin 60 mg/m2 and cisplatin 60 mg/m2 on day 1, plus capecitabine 2000 mg/m2/day as an intermittent regimen of 2 weeks of treatment followed by a 1-week rest. RESULTS: The median age was 49 years (range, 32-64) and 19 patients were hepatitis B virus seropositive. Child-Pugh class was A in all patients and 4 had Zubrod performance status of 2. The objective response rate was 24% (95% CI 9-40) with 6 stable diseases. The chemotherapy was generally well tolerated despite one treatment-related death. CONCLUSION: Combination chemotherapy with doxorubicin, cisplatin and capecitabine produced modest antitumor activity with tolerable adverse effects in patients with metastatic HCC.
26
Optimal two-stage designs for phase II clinical trials
Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations
Classification of chronic hepatitis: Diagnosis, grading and staging
Valeer Desmet, Michael A. Gerber, Jay H. Hoofnagle et al. · Hepatology · 1994 · 2.6K citations
Masanori Miwa, Masako Ura, M Nishida et al. · European Journal of Cancer · 1998 · 1.2K citations
Medicine, Oncology, Pharmacology +12
Paulo M. Hoff, Rafat Ansari, Gerald Batist et al. · Journal of Clinical Oncology · 2001 · 1.1K citations
Medicine, Oncology, Pharmacology +14